Open a bounty challenge Fund this gap and accept submissions. SPEC-033.
Composite
Novelty
Mechanistic
Druggability
Priority
79%
Importance
75%
Tractability
85%
Market price
50%

Description

The abstract explicitly states that quercetin’s potential in GBM has not been adequately explored, despite its known ability to cross the blood-brain barrier and effectiveness against other solid tumors. This represents a clear research gap that could impact therapeutic development for brain cancers.

Gap type: open_question Source paper: Quercetin induces MGMT (None, None, PMID:37451151)